Share Search
Visit the Share Search
Ondine Biomed Accounts Summary
| Date of Accounts | 2022 | 2021 | 2020 | ||
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | ||
| Millions | Millions | Millions | |||
| Income Statement | 31-12-2022 | 31-12-2021 | 31-12-2020 | ||
| Revenue | 0.64 | 2.57 | 1.79 | ||
| Operating Profit / Loss | -18.76 | -17.52 | -15.87 | ||
| Net Interest | -0.19 | n/a | -0.49 | ||
| Pre Tax Profit | -19.37 | -50.09 | -16.27 | ||
| Post Tax Profit | -19.37 | -50.09 | -16.27 | ||
| Profit for the Period | -19.37 | -50.08 | -16.27 | ||
| Equity Holders of Parent Company | -19.37 | -50.08 | -16.27 | ||
| Minority Interests | n/a | n/a | n/a | ||
| Continuing EPS | |||||
| Earnings per Share (Basic) | -10.00 CAX | -63.00 CAX | -23.00 CAX | ||
| Earnings per Share (Diluted) | -10.00 CAX | -63.00 CAX | -23.00 CAX | ||
| Earnings per Share (Adjusted) | -10.00 CAX | -63.00 CAX | -23.00 CAX | ||
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | -10.00 CAX | -63.00 CAX | -23.00 CAX | ||
| Earnings per Share (Diluted) | -10.00 CAX | -63.00 CAX | -23.00 CAX | ||
| Earnings per Share (Adjusted) | -10.00 CAX | -63.00 CAX | -23.00 CAX | ||
| Dividend per Share | n/a CAD | n/a CAD | n/a CAD | ||
| Millions | Millions | Millions | |||
| Balance Sheet | 31-12-2022 | 31-12-2021 | 31-12-2020 | ||
| Non-Current Assets | |||||
| Intangible Assets | n/a | n/a | 0.17 | ||
| Property, Plant and Equipment | 1.40 | 0.60 | 0.67 | ||
| Investments | n/a | n/a | n/a | ||
| Investment Properties | n/a | n/a | n/a | ||
| Other Financial Assets | n/a | n/a | n/a | ||
| Other Non-Current Assets | 0.04 | 0.04 | 0.05 | ||
| Total Non-Current Assets | 1.44 | 0.64 | 0.89 | ||
| Current Assets | |||||
| Inventories | 1.29 | 1.06 | 0.40 | ||
| Trade and Other Receivables | 0.56 | 2.08 | 0.72 | ||
| Cash at Bank and in Hand | 13.12 | 30.36 | 0.63 | ||
| Current Asset Investments | n/a | n/a | n/a | ||
| Other Current Assets | 0.15 | n/a | n/a | ||
| Total Current Assets | 15.13 | 33.50 | 1.75 | ||
| Other Assets | n/a | n/a | n/a | ||
| Total Assets | 16.57 | 34.14 | 2.63 | ||
| Current Liabilities | |||||
| Borrowings | 0.36 | 0.15 | 34.37 | ||
| Other Current Liabilities | 3.55 | 3.77 | 1.41 | ||
| Total Current Liabilities | 3.91 | 3.92 | 35.79 | ||
| Net Current Assets | n/a | n/a | n/a | ||
| Non-Current Liabilities | |||||
| Borrowings | 0.54 | 0.09 | 0.09 | ||
| Provisions | n/a | n/a | n/a | ||
| Other Non-Current Liabilities | 0.48 | 0.47 | 0.59 | ||
| Total Non-Current Liabilities | 1.02 | 0.56 | 0.68 | ||
| Net Assets | 11.64 | 29.66 | -33.83 | ||
| Capital and Reserves | |||||
| Share Capital | 235.04 | 235.04 | 119.53 | ||
| Share Premium Account | 10.53 | 10.53 | 10.38 | ||
| Other Reserves | 18.00 | 16.64 | 18.41 | ||
| Retained Earnings | -251.92 | -232.54 | -182.14 | ||
| Shareholders Funds | 11.64 | 29.66 | -33.81 | ||
| Minority Interests / Other Equity | n/a | n/a | -0.01 | ||
| Total Equity | 11.64 | 29.66 | -33.83 | ||
| 31-12-2022 | 31-12-2021 | 31-12-2020 | |||
| Operating Margin | -2,940.91% | -681.98% | -886.15% | ||
| Return on Capital Employed | -152.96% | -167.51% | -3,437.89% | ||
| Dividend Cover | n/a | n/a | n/a | ||
| Dividend Yield | n/a | n/a | n/a | ||
| PE Ratio | n/a | n/a | n/a | ||
| PEG | n/a | n/a | n/a | ||
| Dividend per Share Growth | n/a% | n/a% | n/a% | ||
| Net Asset Value per Share | 0.06 CAD | 0.15 CAD | -0.17 CAD |